Efficacy of Immune Checkpoint Inhibitors in Metastatic Melanoma (MM) Patients with Concurrent Chronic Lymphocytic Leukemia (CLL)

被引:0
|
作者
Guerra, Veronica [1 ]
Ologun, Gabriel [2 ]
Haydu, Lauren [2 ]
Keung, Emily [2 ]
Burton, Elizabeth [2 ]
Tawbi, Hussein [3 ]
Davis, Michael [3 ]
Wargo, Jennifer [2 ]
Ferrajoli, Alessandra [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA
来源
关键词
chronic lymphocytic leukemia; CLL; melanoma; immune checkpoint inhibitors; nivolumab; ipilimumab; pembrolizumab;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
CLL-229
引用
收藏
页码:S225 / S225
页数:1
相关论文
共 50 条
  • [21] Outcomes of immune checkpoint inhibitors in patients with metastatic uveal melanoma treated with tebentafusp
    Koch, E. C.
    Ceballos, D. P. Arteaga
    Vilbert, M.
    Lajkosz, K.
    Muniz, T. Pimentel
    Hirsch, I.
    Ribeiro, M. F. Silva Almeida
    Mantle, L.
    Anczurowski, M.
    Hogg, D.
    Saibil, S.
    Spreafico, A.
    Krema, H.
    Butler, M. O.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S928 - S928
  • [22] Association of Impaired Spermatogenesis With the Use of Immune Checkpoint Inhibitors in Patients With Metastatic Melanoma
    Scovell, Jason M.
    Benz, Karl
    Samarska, Iryna
    Kohn, Taylor P.
    Hooper, Jody E.
    Matoso, Andres
    Herati, Amin S.
    JAMA ONCOLOGY, 2020, 6 (08) : 1297 - 1299
  • [23] Immune checkpoint inhibitors retain effectiveness in older patients with cutaneous metastatic melanoma
    Howell, Ashley, V
    Gebregziabher, Mulugeta
    Thiers, Bruce H.
    Paulos, Chrystal M.
    Wrangle, John M.
    Hunt, Kelly J.
    Wallace, Kristin
    JOURNAL OF GERIATRIC ONCOLOGY, 2021, 12 (03) : 394 - 401
  • [24] Plasma proteomics in patients with metastatic cutaneous melanoma treated with immune checkpoint inhibitors
    Eriksson, H.
    Babic, H.
    Lehtio, J.
    Pernemalm, M.
    ANNALS OF ONCOLOGY, 2019, 30 : 536 - 536
  • [25] Efficacy of immune checkpoint inhibitors (ICIs) in advanced mucosal melanoma (MM): A systematic review and metaanalysis
    Pham, J. P.
    Hurwitz, J.
    Cosman, R.
    Goldinger, S. M.
    Sim, H. W.
    Dummer, R.
    Joshua, A. M.
    ANNALS OF ONCOLOGY, 2023, 34 : S677 - S677
  • [26] Immune checkpoint inhibitor treatment of advanced age metastatic melanoma (MM) patients.
    Hegde, Upendra P.
    Kerr, Phil
    Masternak, Sophie
    Brenner, Bruce Mark
    Grant-Kels, Jane
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [27] B Cell Subsets and Immune Checkpoint Expression in Patients with Chronic Lymphocytic Leukemia
    Ntsethe, Aviwe
    Mkhwanazi, Zekhethelo Alondwe
    Dludla, Phiwayinkosi Vusi
    Nkambule, Bongani Brian
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2024, 46 (03) : 1731 - 1740
  • [28] Efficacy of immune checkpoint inhibitors in different types of melanoma
    Rossi, Ernesto
    Schinzari, Giovanni
    Maiorano, Brigida Anna
    Indellicati, Giulia
    Di Stefani, Alessandro
    Pagliara, Monica Maria
    Fragomeni, Simona Maria
    De Luca, Erika Valentina
    Sammarco, Maria Grazia
    Garganese, Giorgia
    Galli, Jacopo
    Blasi, Maria Antonietta
    Paludetti, Gaetano
    Scambia, Giovanni
    Peris, Ketty
    Tortora, Giampaolo
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (01) : 4 - 13
  • [29] Efficacy of immune checkpoint inhibitors for in-transit melanoma
    Nan Tie, Emilia
    Lai-Kwon, Julia
    Rtshiladze, Michael Alexander
    Na, Lumine
    Bozzi, James
    Read, Tavis
    Atkinson, Victoria
    Au-Yeung, George
    Long, Georgina
    McArthur, Grant A.
    Sandhu, Shahneen
    Saw, Robyn
    Walpole, Euan
    Menzies, Alexander
    Smithers, Mark
    Gyorki, David E.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
  • [30] SAFETY, EFFICACY AND IMMUNE EFFECTS OF VENETOCLAX 400 MG DAILY IN PATIENTS (PTS) WITH RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
    Anderson, M. A.
    Roberts, A. W.
    Seymour, J. F.
    Gerecitano, J. F.
    Kahl, B. S.
    Kipps, T. J.
    Pagel, J. M.
    Puvvada, S. D.
    Wierda, W. G.
    Gressick, L.
    Zhu, M.
    Dunbar, M.
    Chyla, B.
    Verdugo, M.
    Kim, S. Y.
    Davids, M. S.
    HAEMATOLOGICA, 2016, 101 : 228 - 228